Etiopathogenic and Clinical Aspects in Inflammatory Bowel Disease – Literature Review

Isac, Petronela Nicoleta Seritean; Popescu, Diana; Genes, Tudor Marcel; Badescu, Minerva Codruta; Rezus, Ioana Irina; Dima, Nicoleta; Ganceanu, Ana Roxana Rusu; Rezus, Elena; Rezus, Ciprian

doi:10.2478/jim-2021-0031

References

1. Zhao J, Lu Q, Liu Y, et al. Th17 Cells in Inflammatory Bowel Disease: Cytokines, Plasticity, and Therapies. Journal of Immunology Research. 2021;1-14.10.1155/2021/8816041784640433553436
Search in Google Scholar Back to article
2. Jang HJ, Kang B, Choe BH. The difference in extraintestinal manifestations of inflammatory bowel disease for children and adults. Transl Pediatr. 2019;8:4-15.10.21037/tp.2019.01.06638250130881893
Search in Google Scholar Back to article
3. Martinez-Fierro ML, Garza-Veloz I, Rocha-Pizaña MR, et al. Serum cytokine, chemokine, and growth factor profiles and their modulation in inflammatory bowel disease. Medicine (Baltimore). 2019;98:e17208.10.1097/MD.0000000000017208675669031567972
Search in Google Scholar Back to article
4. Kim JM, Cheon JH. Pathogenesis and clinical perspectives of extraintestinal manifestations in inflammatory bowel diseases. Intest Res. 2020;18:249-264.10.5217/ir.2019.00128738558132295331
Search in Google Scholar Back to article
5. Ma C, Vasu R, Zhang H. The Role of Long-Chain Fatty Acids in Inflammatory Bowel Disease. Mediators Inflamm. 2019;2019: 8495913.10.1155/2019/8495913687487631780872
Search in Google Scholar Back to article
6. Malaty HM, Lo GH, Hou JK. Characterization and prevalence of spondyloarthritis and peripheral arthritis among patients with inflammatory bowel disease. Clin Exp Gastroenterol. 2017;10:259-263.10.2147/CEG.S136383562773629026327
Search in Google Scholar Back to article
7. Chams S, Badran R, Sayegh SE, Chams N, Shams A, Hajj Hussein I. Inflammatory bowel disease: Looking beyond the tract. Int J Immunopathol Pharmacol. 2019;33:1-18.10.1177/2058738419866567668511331382828
Search in Google Scholar Back to article
8. Kotze LM, Costa CT, Cavassani MF, Nisihara RM. Alert for bone alterations and low serum concentrations of vitamin D in patients with intestinal inflammatory disease. Rev Assoc Med Bras. 2017;63:13-17.10.1590/1806-9282.63.01.1328225873
Search in Google Scholar Back to article
9. Ungureanu L, Cosgarea R, Alexandru Badea M, et al. Cutaneous manifestations in inflammatory bowel disease (Review). Exp Ther Med. 2020;20:31-37.10.3892/etm.2019.8321
Search in Google Scholar Back to article
10. Antonelli E, Bassotti G, Tramontana M, et al. Dermatological Manifestations in Inflammatory Bowel Diseases. J Clin Med. 2021;10;1-16.10.3390/jcm10020364783597433477990
Search in Google Scholar Back to article
11. Lauritano D, Boccalari E, Di Stasio D, et al. Prevalence of Oral Lesions and Correlation with Intestinal Symptoms of Inflammatory Bowel Disease: A Systematic Review. Diagnostics (Basel). 2019;9:1-16.10.3390/diagnostics9030077678770431311171
Search in Google Scholar Back to article
12. Kumar KM, Nachiammai N, Madhushankari GS. Association of oral manifestations in ulcerative colitis: A pilot study. J Oral Maxillofac Pathol. 2018;22:199-203.10.4103/jomfp.JOMFP_223_16609737330158772
Search in Google Scholar Back to article
13. Troncoso LL, Biancardi AL, de Moraes HV Jr, Zaltman C. Ophthalmic manifestations in patients with inflammatory bowel disease: a review. World J Gastroenterol. 2017;23:5836-5848.10.3748/wjg.v23.i32.5836558356928932076
Search in Google Scholar Back to article
14. Silva J, Brito BS, de N. Silva IN, et al. Frequency of Hepatobiliary Manifestations and Concomitant Liver Disease in Inflammatory Bowel Disease Patients. Biomed Res Int. 2019;2019:7604939.10.1155/2019/7604939637487830834274
Search in Google Scholar Back to article
15. de Vries AB, Janse M, Blokzijl H, Weersma RK. Distinctive inflammatory bowel disease phenotype in primary sclerosing cholangitis. World J Gastroenterol. 2015;21:1956-1971.10.3748/wjg.v21.i6.1956432347625684965
Search in Google Scholar Back to article
16. Fousekis FS, Theopistos VI, Katsanos KH, et al. Hepatobiliary Manifestations and Complications in Inflammatory Bowel Disease: A Review. Gastroenterol Res. 2018;11:83-94.10.14740/gr990w591663129707074
Search in Google Scholar Back to article
17. Iida T, Wagatsuma K, Hirayama D, Yokoyama Y, Nakase H. The Etiology of Pancreatic Manifestations in Patients with Inflammatory Bowel Disease. J Clin Med. 2019;8:916.10.3390/jcm8070916667903631247968
Search in Google Scholar Back to article
18. Fousekis FS, Theopistos VI, Katsanos KH, Christodoulou DK. Pancreatic Involvement in Inflammatory Bowel Disease: A Review. J Clin Med Res. 2018;10:743-751.10.14740/jocmr3561w613500330214645
Search in Google Scholar Back to article
19. Kacprzak A, Szturmowicz M, Kus J. Respiratory system involvement in inflammatory bowel diseases. Adv Respir Med. 2017;85:161-168.10.5603/ARM.2017.002828667659
Search in Google Scholar Back to article
20. Ji XQ, Wang LX, Lu DG. Pulmonary manifestations of inflammatory bowel disease. World J Gastroenterol. 2014;20:13501-13511.10.3748/wjg.v20.i37.13501418890125309080
Search in Google Scholar Back to article
21. Xu L, Xiao W, Ma D, Zhou S, Zhang Q. Ulcerative colitis combined with acute interstitial lung disease and airway disease: A case report and literature review. Exp Ther Med. 2014;8:1229-1236.10.3892/etm.2014.1895415178225187830
Search in Google Scholar Back to article
22. Bunu DM, Timofte CE, Ciocoiu M, et al. Cardiovascular Manifestations of Inflammatory Bowel Disease: Pathogenesis, Diagnosis, and Preventive Strategies. Gastroenterol Res Pract. 2019;2019:3012509.10.1155/2019/3012509634881830733802
Search in Google Scholar Back to article
23. Harbord M, Annese V, Vavricka SR, et al. The First European Evidence-based Consensus on Extra-intestinal Manifestations in Inflammatory Bowel Disease. J Crohns Colitis. 2016;10:239-254.10.1093/ecco-jcc/jjv213495747626614685
Search in Google Scholar Back to article
24. Mitchell NE, Harrison N, Junga Z, Singla M. Heart Under Attack: Cardiac Manifestations of Inflammatory Bowel Disease. Inflamm Bowel Dis. 2018;24:2322-2326.10.1093/ibd/izy15729788235
Search in Google Scholar Back to article
25. Ali SA, Abbasi Z, Shahid B, et al. The prevalence, characteristics, and determinants of anaemia in newly diagnosed patients with inflammatory bowel disease. Gastroenterology Rev. 2019;14:39-47.10.5114/pg.2019.83424644410430944676
Search in Google Scholar Back to article
26. Tulewicz-Marti E, Moniuszko A, Rydzewska G. Management of anemia in inflammatory bowel disease: a challenge in everyday clinical practice. Gastroenterol Rev. 2017;12:239-243.10.5114/pg.2017.72096577144629358991
Search in Google Scholar Back to article
27. Nemes RM, Pop CS, Calagiu D, et al. Anemia in inflammatory bowel disease more than an extraintestinal complication. Rev Med Chir. 2016;120:34-39.
Search in Google Scholar Back to article
28. Epistola R, Do T, Vankina R, et al. Immune thrombocytopenic purpura (ITP) as an uncommon extraintestinal complication of Crohn’s disease: case vignette and systematic literature review. Case Rep Hematol. 2020;2020:4785759.10.1155/2020/4785759713677032274225
Search in Google Scholar Back to article
29. Jimenez K, Kulnigg-Dabsch S, Gasche C. Management of Iron Deficiency Anemia. Gastroenterol Hepatol (N Y). 2015;11:241-250.
Search in Google Scholar Back to article
30. Fagagnini S, Heinrich H, Rossel JB, et al. Risk factors for gallstones and kidney stones in a cohort of patients with inflammatory bowel diseases. PLoS ONE. 2017;12:e0185193.10.1371/journal.pone.0185193563823529023532
Search in Google Scholar Back to article
31. Pittet V, Juillerat P, Mottet C, et al. Cohort Profile: The Swiss Inflammatory Bowel Disease Cohort Study (SIBDCS). Int J Epidemiol. 2009;38:922-931.10.1093/ije/dyn18018782896
Search in Google Scholar Back to article
32. Li M, Yang QF, Cao Q, et al. High-risk human papilloma virus infection and cervical neoplasm in female inflammatory bowel disease patients: a cross-sectional study. Gastroenterol Rep (Oxf). 2019;7:338-344.10.1093/gastro/goy053682121931687153
Search in Google Scholar Back to article
33. Kuźnicki P, Kempiński R, Neubauer K. The emerging role of mood disorders in inflammatory bowel diseases. Adv Clin Exp Med. 2020;29:1505-1510.10.17219/acem/12767633389842
Search in Google Scholar Back to article
34. Davis SP, Bolin LP, Crane PB, Crandell J. Non-pharmacological Interventions for Anxiety and Depression in Adults With Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis. Front Psychol. 2020;11:538741.10.3389/fpsyg.2020.538741767629333250803
Search in Google Scholar Back to article
35. Singh S, Kumar N, Loftus EV Jr, Kane SV. Neurologic complications in patients with inflammatory bowel disease: increasing relevance in the era of biologics. Inflamm Bowel Dis. 2013;19:864-872.10.1002/ibd.2301122552994
Search in Google Scholar Back to article
36. Ott C, Schölmerich J. Extraintestinal manifestations and complications in IBD. Nat Rev Gastroenterol Hepatol. 2013;10:585-595.10.1038/nrgastro.2013.11723835489
Search in Google Scholar Back to article

Etiopathogenic and Clinical Aspects in Inflammatory Bowel Disease – Literature Review

References

Paradigm

My account